We’re testing a new AI assistant to help patients, caregivers, and researchers find information faster. Click the FCF Assistant button in the lower right corner to try it.
Goal: Advance understanding of FLC’s unique tumor microenvironment Principal Investigator: Praveen Sethupathy, PhD Grant length: Two years Study overview: Through this grant, Praveen Sethupathy, PhD, of Cornell University plans to outline the “spatial transcriptomics” of FLC. Dr. Sethupathy’s lab has been a leader in functional genomic studies, especially for liver and gastro-intestinal cancers. His group …
Goal: Investigate the applicability of using an FDA-approved device to treat fibrolamellar patients Principal Investigator: Hugo Jimenez, PhD Grant length: One year, plus extension Study overview: In this study, Dr. Jimenez and his team will conduct initial feasibility testing with a device that delivers low energy amplitude modulated 27.12 MHz radiofrequency electromagnetic fields (AM RF …
Goal: Provide the drug necessary to enable a FLC clinical trial Principal Investigators of related clinical study: Dr. Allison O’Neill, Dana-Farber Cancer Institute and Dr. Michael Ortiz, Memorial Sloan Kettering Cancer Center Grant length: Three years Effort overview: This grant funds the manufacturing and distribution of an experimental drug, DT2216, for a clinical trial for …